| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |